What is Merrimack Pharmaceuticals, Inc. (MACK)?

Merrimack Pharmaceuticals, Inc. (MACK) is a stock in the Healthcare sector, Biotechnology industry. View full analysis on Stocks360.

What is the current price of MACK?

The current price of MACK is $15.15. Prices are updated in real time on Stocks360.

What is MACK's price-to-earnings (PE) ratio?

MACK's trailing twelve-month PE ratio is -183.35, based on current price and earnings per share data available on Stocks360.

What is MACK's market capitalization?

MACK's market capitalization is $223,970,318.00, placing it in the small-cap tier.

Does MACK pay a dividend?

Yes. MACK has a trailing twelve-month dividend yield of 1.00%. Dividend data is sourced from financial market providers and displayed on Stocks360.

Merrimack Pharmaceuticals, Inc. (MACK)

Stock analysis · NASDAQ · Healthcare · Biotechnology

$15.15

Market Cap

$223.97M

PE (TTM)

-183.35

EPS (TTM)

N/A

Dividend Yield

99.70%

Beta

1.42

Day Range

$15.14 – $15.17

52-wk Range

$11.53 – $15.89

Avg Volume

N/A

Volume

922.50K

Merrimack Pharmaceuticals, Inc. (MACK) is a publicly traded company in the Healthcare sector. Latest price: $15.15. Market cap $223.97M. Trailing PE -183.35. Dividend yield 99.70%. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Earnings

Most Recent

Mar 6, 2019

EPS $-0.97 vs est. $-1.01

Beat by $0.04

Proprietary Signals

Signal snapshot temporarily unavailable.

About Merrimack Pharmaceuticals, Inc.

Founded in 1993, Merrimack Pharmaceuticals, Inc. is a biopharmaceutical company headquartered in Cambridge, Massachusetts.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-183.35×
P/S (TTM)	0.00×
P/B	11.55×
PEG	0.06×
P/FCF (TTM)	-147.16×
EV / EBITDA	100.18×
EV / Sales	0.00×
Earnings Yield	-0.55%
Free Cash Flow Yield	-0.68%
Dividend Yield	99.70%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$217.98M
Net Income (TTM)	-$1.22M
Free Cash Flow (TTM)	-$1.52M
Net Debt	-$5.99M
Working Capital	$18.74M
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Return on Equity	-6.22%
Return on Invested Capital	-11.61%